Generated by GPT-5-mini| European Society for Medical Oncology | |
|---|---|
| Name | European Society for Medical Oncology |
| Abbreviation | ESMO |
| Formation | 1975 |
| Type | Professional association |
| Headquarters | Geneva, Switzerland |
| Region served | Europe |
| Membership | Oncology professionals |
| Leader title | President |
European Society for Medical Oncology is a professional association focused on clinical oncology, oncology research, and cancer care policy in Europe. It convenes clinicians, researchers, and allied professionals around standards for cancer treatment and prevention, collaborating with academic institutions, regulatory bodies, and patient organizations across the continent. The society engages with international partners, national oncology societies, and multidisciplinary coalitions to influence clinical practice, education, and research funding priorities.
The society was founded in 1975 during a period of growing specialization in oncology involving figures associated with Institut Gustave Roussy, Royal Marsden Hospital, Istituto Nazionale dei Tumori, Karolinska Institute, and Odense University Hospital, and it developed ties with organizations such as Union for International Cancer Control, European Commission, World Health Organization, and Council of Europe. Throughout the 1980s and 1990s it expanded programs that paralleled initiatives at European Organisation for Research and Treatment of Cancer, American Society of Clinical Oncology, National Cancer Institute (United States), and European Medicines Agency. In the 2000s the society increased emphasis on harmonizing clinical guidelines, engaging with NICE (United Kingdom), Haute Autorité de Santé, Deutsche Krebsgesellschaft, and national health ministries, and it participated in collaborative projects with Horizon 2020, European Research Council, and multinational cooperative groups. Recent developments saw growth in global outreach with connections to Asian Pacific Society of Medical Oncology, American Society of Clinical Oncology Foundation, Union for International Cancer Control (UICC), and various patient advocacy groups such as European Cancer Patient Coalition.
The society’s mission emphasizes improving outcomes for patients with cancer by promoting evidence-based practice through partnerships with institutions like Johns Hopkins Hospital, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and MD Anderson Cancer Center. Activities include guideline development alongside agencies such as European Medicines Agency and International Atomic Energy Agency, advocacy initiatives addressing access to medicines in contexts involving World Trade Organization agreements, and collaborations with organizations like European Parliamentary Forum on Cancer Control and European Patients' Forum. Programs span quality improvement efforts partnered with Organisation for Economic Co-operation and Development, policy dialogues with European Parliament, and capacity-building ventures with national cancer centers including Gustave Roussy, Institut Curie, and Istituto Nazionale Tumori.
Membership comprises medical oncologists, oncology nurses, oncology pharmacists, and researchers affiliated with institutions such as University of Oxford, University of Cambridge, Heidelberg University Hospital, Karolinska University Hospital, and University of Barcelona. Governance features an elected leadership structure including presidents and committees drawing from professionals linked to Royal College of Physicians, European Federation of National Associations of Orthopaedics and Traumatology, and national societies like Associazione Italiana di Oncologia Medica. The society interacts with regulatory and professional stakeholders including European Medicines Agency, European Commission Directorate-General for Health and Food Safety, and national ministries of health, and it organizes advisory bodies similar to those of National Institute for Health and Care Excellence and Institut National du Cancer.
Educational offerings include an annual congress that attracts delegations affiliated with European Congress of Radiology, American Society of Clinical Oncology Annual Meeting, and specialty meetings connected to European Association of Urology, European Respiratory Society, and European Association for the Study of the Liver. Training programs, fellowships, and certification courses are offered in partnership with universities such as Università degli Studi di Milano, KU Leuven, Université Paris Cité, and Charité – Universitätsmedizin Berlin. The society collaborates on workshops and symposia with professional bodies including British Society for Haematology, International Society of Paediatric Oncology, and European Society for Radiotherapy and Oncology.
The society develops clinical practice guidelines and consensus recommendations in areas linked to institutions like European Organisation for Research and Treatment of Cancer, Cancer Research UK, and trial networks such as EORTC, Trans-Tasman Radiation Oncology Group, and cooperative groups that include German Cancer Aid. Research activities encompass translational and clinical trials involving targeted therapy research connected to Institute of Cancer Research (London), immuno-oncology studies in collaboration with Karolinska Institute, and biomarker-driven trials coordinated with European Biomarkers Consortium and European Molecular Biology Laboratory. Guideline development processes mirror methods used by National Comprehensive Cancer Network, Scottish Intercollegiate Guidelines Network, and Australian Cancer Network to address areas such as systemic therapy, supportive care, and survivorship.
The society publishes peer-reviewed content and educational resources analogous to outputs from The Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, and collaborates with scientific publishers and indexing services including PubMed, Scopus, and Web of Science. Communications include position papers, policy briefs, and clinical tools disseminated via congress proceedings and digital platforms used by institutions such as European Bioinformatics Institute and CERN for data-sharing. It also engages with patient advocacy publications and media outlets linked to European Health Forum Gastein and professional news services.
Category:Medical associations based in Europe Category:Oncology organizations